NanoBio nabs $6M vax grant

NanoBio, a promising spinoff from the University of Michigan, nabbed a $6 million grant from the Gates Foundation for its work on a new nasal spray vaccine. NanoBio has been using its cutting edge nanoemulsion technology for a number of development programs. Gates' money will be spent in pursuit of a new treatment for RSV. Story

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.